Acorda Therapeutics
ACOR
$0.55
Share price
-7.70%
Change (1 day)
25.86%
Change (1 year)
Categories
Earnings for Acorda Therapeutics (ACOR)
Earnings in 2022 (TTM): -$15.9 M
According to Acorda Therapeutics 's latest financial reports the company's current earnings (TTM) are -$15.9 M. an increase over its 2021 earnings that were of -$77.3 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Acorda Therapeutics from 2006 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 | -$15.9 M | -79.44% |
| 2021 | -$77.3 M | -11.05% |
| 2020 | -$86.9 M | -28.19% |
| 2019 | -$0.13 B | -229.44% |
| 2018 | $93.48 M | -11.11% |
| 2017 | $0.10 B | -1169.77% |
| 2016 | -$9.84 M | -121.9% |
| 2015 | $44.89 M | -1.52% |
| 2014 | $45.58 M | 50.12% |
| 2013 | $30.36 M | 18.6% |
| 2012 | $25.6 M | -27.5% |
| 2011 | $35.31 M | |
| 2009 | -$81.26 M | 10.65% |
| 2008 | -$73.44 M | 86.17% |
| 2007 | -$39.45 M | 68.1% |
| 2006 | -$23.47 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | -$1.1 B | 6,811.17% | 🇺🇸 USA |
 Repligen
RGEN | $0.19 B | -1,342.16% | 🇺🇸 USA |
 Affimed
AFMD | -$90.9 M | 471.86% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $72.14 M | -553.89% | 🇺🇸 USA |